BD Named One of America's Most Innovative Companies by Fortune

31.03.25 12:50 Uhr

Werte in diesem Artikel

FRANKLIN LAKES, N.J., March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture.

BD (Becton, Dickinson and Company) Logo (PRNewsfoto/BD (Becton, Dickinson and Company))

"As one of the largest manufacturers of medical devices in the world whose products touch billions of patients around the globe, building on our long history of innovation is a responsibility we take very seriously," said Tom Polen, chairman, CEO and president of BD. "Through the ingenuity of our world-class team who strives to address unmet needs in healthcare every day, coupled with BD Excellence - our culture of continuous improvement - we can live our purpose and manufacture innovative medical products at scale as we deliver for our customers and the patients we serve."

Fortune and Statista surveyed more than 40,000 U.S. employees and more than 2,500 industry experts to rank companies across the following three categories:

  • Product innovation: Regular introduction of new products or services and improvement of existing products and services, in addition to the number and relevance of industrial property rights in the form of patents.
  • Process innovation: Development and use of new and innovative technologies and production processes, as well as the innovative use of digitalization and the resulting opportunities.
  • Innovation culture: Extent a company fosters a spirit of entrepreneurship and creativity, encouraging their employees to take initiative and develop new ideas.
  • For a full list of awards and recognitions BD has received, visit news.bd.com/Award-news.

    About BD
    BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

    Media:
    Jessica Offerjost
    BD Public Relations
    201-258-0964
    jessica.offerjost@bd.com

    Investors:
    Adam Reiffe
    Sr. Director, Investor Relations
    201-847-6927
    adam.reiffe@bd.com 

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-named-one-of-americas-most-innovative-companies-by-fortune-302413488.html

    SOURCE BD (Becton, Dickinson and Company)

    In eigener Sache

    Übrigens: Becton, Dickinson und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

    Ausgewählte Hebelprodukte auf Becton, Dickinson

    Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Becton, Dickinson

    NameHebelKOEmittent
    NameHebelKOEmittent
    Wer­bung

    Nachrichten zu Becton, Dickinson & Co. (BD)

    Wer­bung

    Analysen zu Becton, Dickinson & Co. (BD)

    DatumRatingAnalyst
    13.05.2019Becton, DickinsonCo (BD) OverweightBarclays Capital
    07.12.2018Becton, DickinsonCo (BD) BuyDeutsche Bank AG
    16.10.2018Becton, DickinsonCo (BD) Equal WeightBarclays Capital
    09.03.2018Becton, DickinsonCo (BD) Market PerformBMO Capital Markets
    29.12.2017Becton, DickinsonCo (BD) BuyDeutsche Bank AG
    DatumRatingAnalyst
    13.05.2019Becton, DickinsonCo (BD) OverweightBarclays Capital
    07.12.2018Becton, DickinsonCo (BD) BuyDeutsche Bank AG
    09.03.2018Becton, DickinsonCo (BD) Market PerformBMO Capital Markets
    29.12.2017Becton, DickinsonCo (BD) BuyDeutsche Bank AG
    19.08.2015Becton, DickinsonCo (BD) BuyArgus Research Company
    DatumRatingAnalyst
    16.10.2018Becton, DickinsonCo (BD) Equal WeightBarclays Capital
    03.11.2017Becton, DickinsonCo (BD) Sector PerformRBC Capital Markets
    09.05.2016Becton, DickinsonCo (BD) Sector PerformRBC Capital Markets
    10.08.2015Becton, DickinsonCo (BD) HoldDeutsche Bank AG
    07.08.2015Becton, DickinsonCo (BD) Sector PerformRBC Capital Markets
    DatumRatingAnalyst

    Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

    Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

    Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Becton, Dickinson & Co. (BD) nach folgenden Kriterien zu filtern.

    Alle: Alle Empfehlungen

    Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
    Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
    Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
    mehr Analysen